Publikationen 2019

Albers P, Bögemann M, Machtens S, Merseburger AS, Schostak M, Steuber T, Wülfing C, De Santis M.
[Changes in the treatment of metastatic prostate cancer-new data and open questions].
Urologe A. 2019 Nov 28.
doi: 10.1007/s00120-019-01072-0. [Epub ahead of print] German. PubMed PMID: 31781782.

Albers P, Shafey A, Assmus M, Metcalfe P.
Witnessed Torsion in Extremely Premature Newborns: 2 Cases of Testicular Salvage in the NICU.
Urology. 2020 Jan;135:136-138.
doi: 10.1016/j.urology.2019.07.048. Epub 2019 Sep 27. PubMed PMID: 31568794.

Albers P.
Volume Matters: Can We Rely on the Evidence?
Eur Urol Oncol. 2019 May;2(3):274-275.
doi: 10.1016/j.euo.2019.04.001. Epub 2019 Apr 19. PubMed PMID: 31200841.

Alberts AR, Roobol MJ, Verbeek JFM, Schoots IG, Chiu PK, Osses DF, Tijsterman JD, Beerlage HP, Mannaerts CK, Schimmöller L, Albers P, Arsov C.
Prediction of High-grade Prostate Cancer Following Multiparametric Magnetic Resonance Imaging: Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculators.
Eur Urol. 2019 Feb;75(2):310-318.
doi: 10.1016/j.eururo.2018.07.031. Epub 2018 Aug 3. PubMed PMID: 30082150.

Bagrodia A, Pierorazio P, Singla N, Albers P.
The Complex and Nuanced Care for Early-stage Testicular Cancer: Lessons from the European Association of Urology and American Urological Association Testis Cancer Guidelines.
Eur Urol. 2019 Oct 28. pii: S0302-2838(19)30769-9.
doi: 10.1016/j.eururo.2019.10.003. [Epub ahead of print] PubMed PMID: 31672465.

Bamias A, Tzannis K, Bamia C, Harshman LC, Crabb S, Plimack ER, Pal S, De Giorgi U, Ladoire S, Theodore C, Agarwal N, Yu EY, Niegisch G, Sternberg CN, Srinivas S, Vaishampayan U, Necchi A, Liontos M, Rosenberg JE, Powles T, Bellmunt J, Galsky MD.
The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer.
Oncologist. 2019 Oct;24(10):1348-1355.
doi: 10.1634/theoncologist.2018-0739. Epub 2019 Apr 1. PubMed PMID: 30936379; PubMed Central PMCID: PMC6795165.

Bamias A, Tzannis K, Harshman LC, Crabb SJ, Wong YN, Kumar Pal S, De Giorgi U, Ladoire S, Agarwal N, Yu EY, Niegisch G, Necchi A, Sternberg CN, Srinivas S, Alva A, Vaishampayan U, Cerbone L, Liontos M, Rosenberg J, Powles T, Bellmunt J, Galsky MD.
Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
Ann Oncol. 2019 Nov 1;30(11):1841.
doi: 10.1093/annonc/mdz214. PubMed PMID: 31868903.

Bandini M, Briganti A, Plimack ER, Niegisch G, Yu EY, Bamias A, Agarwal N, Sridhar SS, Sternberg CN, Vaishampayan U, Théodore C, Rosenberg JE, Bellmunt J, Galsky MD, Montorsi F, Necchi A.
Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.
Eur Urol Oncol. 2019 May;2(3):248-256.
doi: 10.1016/j.euo.2018.08.009. Epub 2018 Sep 7. PubMed PMID: 31200838.

Bruins HM, Veskimäe E, Hernández V, Neuzillet Y, Cathomas R, Compérat EM, Cowan NC, Gakis G, Espinós EL, Lorch A, Ribal MJ, Rouanne M, Thalmann GN, Yuan Y,der Heijden AGV, Witjes JA.
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel.
Eur Urol Oncol. 2019 Dec 19. pii: S2588-9311(19)30164-6.
doi: 10.1016/j.euo.2019.11.005. [Epub ahead of print] Review. PubMed PMID: 31866215.

Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G.
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
J Clin Oncol. 2019 Jun 1;37(16):1412-1423.
doi: 10.1200/JCO.18.01480. Epub 2019 Mar 15. PubMed PMID: 30875280; PubMed Central PMCID: PMC6544462.

Fenner M, Oing C, Dieing A, Gauler T, Oechsle K, Lorch A, Hentrich M, Kopp HG, Bokemeyer C, Honecker F.
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group.
J Cancer Res Clin Oncol. 2019 Mar;145(3):717-723.
doi: 10.1007/s00432-018-2752-z. Epub 2018 Sep 19. PubMed PMID: 30232558.

Fischer S, Tandstad T, Cohn-Cedermark G, Thibault C, Vincenzi B, Klingbiel D, Albany C, Necchi A, Terbuch A, Lorch A, Aparicio J, Heidenreich A, Hentrich M, Wheater M, Langberg CW, Ståhl O, Fankhauser CD, Hamid AA, Koutsoukos K, Shamash J, White J, Bokemeyer C, Beyer J, Gillessen S; Global Germ-Cell Cancer Group.
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
J Clin Oncol. 2019 Dec 26:JCO1901876.
doi: 10.1200/JCO.19.01876. [Epub ahead of print] PubMed PMID: 31877087.

Friedersdorff F, Putz J, Dreikorn K, Giessing M, Fornara P, Stöckle M, Schlomm T.
[The 2018 annual report on the 26th annual meeting of the working group for kidney transplantation of the German Society of Urology in Berlin].
Urologe A. 2019 Mar;58(3):324-328.
doi: 10.1007/s00120-019-0873-x. German. PubMed PMID: 30762078.

Gandaglia G, Albers P, Abrahamsson PA, Briganti A, Catto JWF, Chapple CR, Montorsi F, Mottet N, Roobol MJ, Sønksen J, Wirth M, van Poppel H.
Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.
Eur Urol. 2019 Aug;76(2):142-150.
doi: 10.1016/j.eururo.2019.04.033. Epub 2019 May 12. PubMed PMID: 31092338.

Gontero P, Pisano F, Palou J, Joniau S, Albersen M, Colombo R, Briganti A, Pellucchi F, Faba OR, van Rhijn BW, van de Putte EF, Babjuk M, Fritsche HM, Mayr R, Albers P, Niegisch G, Anract J, Masson-Lecomte A, De la Taille A, Roupret M, Peyronnet B, Cai T, Witjes AJ, Bruins M, Baniel J, Mano R, Lapini A, Sessa F, Irani J, Brausi M, Stenzl A, Karnes JR, Scherr D, O'Malley P, Taylor B, Shariat SF, Black P, Abdi H, Matveev VB, Samuseva O, Parekh D, Gonzalgo M, Vetterlein MW, Aziz A, Fisch M, Catto J, Pang KH, Xylinas E, Rink M; Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology.
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases.
World J Urol. 2019 Nov 6.
doi: 10.1007/s00345-019-02982-6. [Epub ahead of print] PubMed PMID: 31691084.

Grunewald CM, Niegisch G.
[Personalised medicine in urothelial bladdercancer].
Aktuelle Urol. 2019 Sep;50(5):502-508.
doi: 10.1055/a-0927-6725. Epub 2019 Jun 13. German. PubMed PMID: 31195416.

Gschwend JE, Heck MM, Lehmann J, Rübben H, Albers P, Wolff JM, Frohneberg D, de Geeter P, Heidenreich A, Kälble T, Stöckle M, Schnöller T, Stenzl A, Müller M, Truss M, Roth S, Liehr UB, Leißner J, Bregenzer T, Retz M.
Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.
Eur Urol. 2019 Apr;75(4):604-611.
doi: 10.1016/j.eururo.2018.09.047. Epub 2018 Oct 15. PubMed PMID: 30337060.

Hallanzy J, Kron M, Goethe VE, Köhn FM, Schmautz M, Arsov C, Hadaschik B, Imkamp F, Gschwend JE, Herkommer K.
Erectile Dysfunction in 45-Year-Old Heterosexual German Men and Associated Lifestyle Risk Factors and Comorbidities: Results From the German Male Sex Study.
Sex Med. 2019 Mar;7(1):26-34.
doi: 10.1016/j.esxm.2018.11.004. Epub 2019 Jan 9. PubMed PMID: 30638828; PubMed Central PMCID: PMC6377383.

Heidenreich A, Albers P.
Ablatio testis und Enukleationsresektion.
Aktuelle Urol. 2019 Feb;50(1):106-112.
doi: 10.1055/a-0652-2713. Epub 2019 Feb 7. German. PubMed PMID: 30731507.

Hiester A, Nettersheim D, Nini A, Lusch A, Albers P.
Management, Treatment, and Molecular Background of the Growing Teratoma Syndrome.
Urol Clin North Am. 2019 Aug;46(3):419-427.
doi: 10.1016/j.ucl.2019.04.008. Epub 2019 May 29. Review. PubMed PMID: 31277736.

Hiester A, Nini A, Fingerhut A, Große Siemer R, Winter C, Albers P, Lusch A.
Preservation of Ejaculatory Function After Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) in Patients With Testicular Cancer: Template vs. Bilateral Resection.
Front Surg. 2019 Jan 17;5:80.
doi: 10.3389/fsurg.2018.00080. eCollection 2018. PubMed PMID: 30705885; PubMed Central PMCID: PMC6345078.

Hiester A, Nini A, Niegisch G, Arsov C, Hautzel H, Antke C, Schimmöller L, Albers P, Rabenalt R.
Oncological outcome of patients treated with spot-specific salvage lymphnode dissection (sLND) for positron-emission tomography (PET)-positive prostate cancer (PCa) relapse.
World J Urol. 2019 Oct;37(10):2081-2090.
doi: 10.1007/s00345-019-02633-w. Epub 2019 Jan 14. PubMed PMID: 30643974.

Horwich A, Babjuk M, Bellmunt J, Bruins HM, Reijke TM, Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, Bari B, Blok W, De Visschere PJL, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, Oyen WJG, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Witjes JA.
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international
collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO
Guidelines Committees†.
Ann Oncol. 2019 Nov 1;30(11):1697-1727.
doi: 10.1093/annonc/mdz296. PubMed PMID: 31740927.

Jaguva Vasudevan AA, Hoffmann MJ, Beck MLC, Poschmann G, Petzsch P, Wiek C, Stühler K, Köhrer K, Schulz WA, Niegisch G.
HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition.
Int J Mol Sci. 2019 Apr 30;20(9). pii: E2135.
doi: 10.3390/ijms20092135. PubMed PMID: 31052182; PubMed Central PMCID: PMC6539474.

Jostes SV, Fellermeyer M, Arévalo L, Merges GE, Kristiansen G, Nettersheim D, Schorle H.
Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate.
Int J Cancer. 2019 Oct 3.
doi: 10.1002/ijc.32714. [Epub ahead of print] PubMed PMID: 31583686.

Jostes S, Nettersheim D, Schorle H.
Epigenetic drugs and their molecular targets in testicular germ cell tumours.
Nat Rev Urol. 2019 Apr;16(4):245-259.
doi: 10.1038/s41585-019-0154-x. Review. PubMed PMID: 30765888.

Lakes J, Arsov C.
[PSA screening and molecular markers].
Urologe A. 2019 May;58(5):486-493.
doi: 10.1007/s00120-019-0900-y. Review. German. PubMed PMID: 30874831.

Lang A, Yilmaz M, Hader C, Murday S, Kunz X, Wagner N, Wiek C, Petzsch P, Köhrer K, Koch J, Hoffmann MJ, Greife A, Schulz WA.
Contingencies of UTX/KDM6A Action in Urothelial Carcinoma.
Cancers (Basel). 2019 Apr 4;11(4). pii: E481.
doi: 10.3390/cancers11040481. PubMed PMID: 30987376; PubMed Central PMCID: PMC6520694.

Maxeiner A, Bichmann A, Oberländer N, El-Bandar N, Sugünes N, Ralla B, Biernath N, Liefeldt L, Budde K, Giessing M, Schlomm T, Friedersdorff F.
Native Nephrectomy before and after Renal Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
J Clin Med. 2019 Oct 4;8(10). pii: E1622.
doi: 10.3390/jcm8101622. PubMed PMID: 31590248; PubMed Central PMCID: PMC6832478.

Meissner VH, Schroeter L, Köhn FM, Kron M, Zitzmann M, Arsov C, Imkamp F, Hadaschik B, Gschwend JE, Herkommer K.
Factors Associated with Low Sexual Desire in 45-Year-Old Men: Findings from the German Male Sex-Study.
J Sex Med. 2019 Jul;16(7):981-991.
doi: 10.1016/j.jsxm.2019.04.018. Epub 2019 Jun 10. PubMed PMID: 31196838.

Moschini M, Xylinas E, Zamboni S, Mattei A, Niegisch G, Yu EY, Bamias A, Agarwal N, Sridhar SS, Sternberg CN, Vaishampayan UN, Rosenberg JE, Bellmunt J, Galsky MD, Montorsi F, Necchi A; RISC Investigators.
Efficacy of Surgery in the Primary Tumor Site for Metastatic Urothelial Cancer: Analysis of an International, Multicenter, Multidisciplinary Database.
Eur Urol Oncol. 2019 Jul 12. pii: S2588-9311(19)30095-1.
doi: 10.1016/j.euo.2019.06.014. [Epub ahead of print] PubMed PMID: 31307962; PubMed Central PMCID: PMC6954983.

Necchi A, Pond GR, Moschini M, Plimack ER, Niegisch G, Yu EY, Bamias A, Agarwal N, Vaishampayan U, Theodore C, Sridhar SS, Rosenberg JE, Bellmunt J, Gallina A, Colombo R, Montorsi F, Briganti A, Galsky MD.
Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer. 2019 Feb;17(1):7-14.e3.
doi: 10.1016/j.clgc.2018.09.008. Epub 2018 Sep 13. PubMed PMID: 30292628; PubMed Central PMCID: PMC6857172.

Nettersheim D, Berger D, Jostes S, Kristiansen G, Lochnit G, Schorle H.
N6-Methyladenosine detected in RNA of testicular germ cell tumors is controlled by METTL3, ALKBH5, YTHDC1/F1/F2, and HNRNPC as writers, erasers, and readers.
Andrology. 2019 Jul;7(4):498-506.
doi: 10.1111/andr.12612. Epub 2019 Mar 23. PubMed PMID: 30903744.

Nettersheim D, Berger D, Jostes S, Skowron M, Schorle H.
Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors.
J Cell Mol Med. 2019 Jan;23(1):670-679.
doi: 10.1111/jcmm.13971. Epub 2018 Nov 20. PubMed PMID: 30460772; PubMed Central PMCID: PMC6307807.

Nettersheim D, Oing C, Schönberger S, Skowron M, Vermeulen M, Müller M, Watolla M, Bremmer F, Pfister D, Calaminus G, Looijenga L, Lorch A, Albers P.
[Current research on pediatric and adult germ cell tumors : A report from the first "Düsseldorfer Testis Cancer Day"].
Urologe A. 2019 Jul;58(7):804-808.
doi: 10.1007/s00120-019-0954-x. German. PubMed PMID: 31119354.

Nettersheim D, Vadder S, Jostes S, Heimsoeth A, Schorle H.
TCam-2 Cells Deficient for SOX2 and FOXA2 Are Blocked in Differentiation and Maintain a Seminoma-Like Cell Fate In Vivo.
Cancers (Basel). 2019 May 25;11(5). pii: E728.
doi: 10.3390/cancers11050728. PubMed PMID: 31130628; PubMed Central PMCID: PMC6562827.

Niegisch G.
Should we spare neoadjuvant chemotherapy in low-risk muscle-invasive bladder cancer patients scheduled for radical cystectomy?
Transl Androl Urol. 2019 Jul;8(Suppl 3):S283-S286.
doi: 10.21037/tau.2019.04.04. PubMed PMID: 31392146; PubMed Central PMCID: PMC6642958.

Niegisch G.
Predicting immune checkpoint inhibitor response in urothelial carcinoma: another step in personalised medicine?
Br J Cancer. 2019 Dec 20.
doi: 10.1038/s41416-019-0684-2. [Epub ahead of print] PubMed PMID: 31857721.

Oing C, Hentrich M, Lorch A, Gläser D, Rumpold H, Ochsenreither S, Richter S, Dieing A, Zschäbitz S, Pereira RR, Bokemeyer C, Seidel C.
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series.
J Cancer Res Clin Oncol. 2019 Dec 14.
doi: 10.1007/s00432-019-03071-2. [Epub ahead of print] PubMed PMID: 31838576.

Oing C, Skowron MA, Bokemeyer C, Nettersheim D.
Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors: past, present, and future considerations.
Andrology. 2019 Jul;7(4):487-497.
doi: 10.1111/andr.12611. Epub 2019 Mar 29. Review. PubMed PMID: 30924611.

Osei Kuffour E, König R, Häussinger D, Schulz WA, Münk C.
ISG15 Deficiency Enhances HIV-1 Infection by Accumulating Misfolded p53.
mBio. 2019 Aug 27;10(4). pii: e01342-19.
doi: 10.1128/mBio.01342-19. PubMed PMID: 31455647; PubMed Central PMCID: PMC6712392.

Pederzoli F, Bandini M, Briganti A, Plimack ER, Niegisch G, Yu EY, Bamias A, Agarwal N, Sridhar SS, Sternberg CN, Vaishampayan UN, Théodore C, Rosenberg JE, Harshman LC, Bellmunt J, Galsky MD, Gallina A, Salonia A, Montorsi F, Necchi A; RISC Investigators.
Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect.
Eur Urol. 2019 Oct;76(4):425-429.
doi: 10.1016/j.eururo.2019.06.032. Epub 2019 Jul 11. PubMed PMID: 31303258; PubMed Central PMCID: PMC6852645.

Perez-Gracia JL, Loriot Y, Rosenberg JE, Powles T, Necchi A, Hussain SA, Morales-Barrera R, Retz MM, Niegisch G, Durán I, Théodore C, Grande E, Shen X, Wang J, Nelson B, Derleth CL, van der Heijden MS.
Corrigendum re: "Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens"
[Eur Urol 2018;73:462-8].
Eur Urol. 2019 Mar;75(3):e82-e83.
doi: 10.1016/j.eururo.2018.11.032. Epub 2018 Nov 28. PubMed PMID: 30502102.

Quentin M, Arsov C, Ullrich T, Valentin B, Hiester A, Blondin D, Albers P, Antoch G, Schimmöller L.
Comparison of analgesic techniques in MRI-guided in-bore prostate biopsy.
Eur Radiol. 2019 Dec;29(12):6965-6970.
doi: 10.1007/s00330-019-06301-w. Epub 2019 Jun 27. PubMed PMID: 31250168.

Sassenberg M, Droop J, Schulz WA, Dietrich D, Loick SM, Wiek C, Scheckenbach K, Gaisa NT, Hoffmann MJ.
Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
BMC Cancer. 2019 Aug 14;19(1):806.
doi: 10.1186/s12885-019-6021-6. PubMed PMID: 31412811; PubMed Central PMCID: PMC6694542.

Sawicki LM, Kirchner J, Buddensieck C, Antke C, Ullrich T, Schimmöller L, Boos J, Schleich C, Schaarschmidt BM, Buchbender C, Heusch P, Rabenalt R, Albers P, Antoch G, Müller HW, Hautzel H.
Prospective comparison of whole-body MRI and (68)Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy.
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1542-1550.
doi: 10.1007/s00259-019-04308-5. Epub 2019 Mar 16. PubMed PMID: 30879122.

Sharma A, Jamil MA, Nuesgen N, Dauksa A, Gulbinas A, Schulz WA, Oldenburg J, El-Maarri O.
Detailed methylation map of LINE-1 5'-promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity.
Mol Genet Genomic Med. 2019 May;7(5):e601.
doi: 10.1002/mgg3.601. Epub 2019 Apr 6. PubMed PMID: 30955237; PubMed Central PMCID: PMC6503062.

Schulz WA, Lang A, Koch J, Greife A.
The histone demethylase UTX/KDM6A in cancer: Progress and puzzles.
Int J Cancer. 2019 Aug 1;145(3):614-620.
doi: 10.1002/ijc.32116. Epub 2019 Jan 28. Review. PubMed PMID: 30628063.

Schulz WA, Sørensen KD.
Epigenetics of Urological Cancers.
Int J Mol Sci. 2019 Sep 26;20(19). pii: E4775.
doi: 10.3390/ijms20194775. PubMed PMID: 31561442; PubMed Central PMCID: PMC6802188.

Skowron MA, Petzsch P, Hardt K, Wagner N, Beier M, Stepanow S, Drechsler M, Rieder H, Köhrer K, Niegisch G, Hoffmann MJ, Schulz WA.
Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell lines.
Sci Rep. 2019 Oct 9;9(1):14476.
doi: 10.1038/s41598-019-50891-w. PubMed PMID: 31597922; PubMed Central PMCID: PMC6785536.

Szarvas T, Jardin-Watelet B, Bourgoin N, Hoffmann MJ, Nyirády P, Oláh C, Széll T, Csizmarik A, Hadaschik B, Reis H.
High-soluble CGA levels are associated with poor survival in bladder cancer.
Endocr Connect. 2019 May 1;8(5):625-633.
doi: 10.1530/EC-19-0068. PubMed PMID: 30999279; PubMed Central PMCID: PMC6510714.

Ullrich T, Arsov C, Quentin M, Laqua N, Klingebiel M, Martin O, Hiester A, Blondin D, Rabenalt R, Albers P, Antoch G, Schimmöller L.
Analysis of PI-RADS 4 cases: Management recommendations for negatively biopsied patients.
Eur J Radiol. 2019 Apr;113:1-6.
doi: 10.1016/j.ejrad.2019.01.030. Epub 2019 Feb 1. PubMed PMID: 30927932.

Ullrich T, Quentin M, Arsov C, Laqua N, Abrar D, Hiester A, Albers P, Antoch G, Schimmöller L.
Value of Dynamic Contrast-Enhanced (DCE) MR Imaging in Peripheral Lesions in PI-RADS-4 Patients.
Rofo. 2019 Oct 17.
doi: 10.1055/a-1020-4026. [Epub ahead of print] PubMed PMID: 31622990.

Weigand K, Friedersdorff F, Apel H, Stöckle M, Putz J, Dreikorn K, Giessing M, Fornara P.
[The 27th annual meeting of the working group kidney transplantation of the German Society for Urology : November 21-24, 2019 in Halle (Saale)].
Urologe A. 2019 Dec 20.
doi: 10.1007/s00120-019-01099-3. [Epub ahead of print] German. PubMed PMID: 31863130.

Whongsiri P, Pimratana C, Wijitsettakul U, Sanpavat A, Jindatip D, Hoffmann MJ, Goering W, Schulz WA, Boonla C.
Oxidative stress and LINE-1 reactivation in bladder cancer are epigenetically linked through active chromatin formation.
Free Radic Biol Med. 2019 Apr;134:419-428.
doi: 10.1016/j.freeradbiomed.2019.01.031. Epub 2019 Jan 29. PubMed PMID: 30703483.

Wirth M, Fossati N, Albers P, Bangma C, Brausi M, Comperat E, Faithfull S, Gillessen S, Jereczek-Fossa BA, Mastris K, Mottet N, Müller SC, Pieters B, Ribal MJ, Sangar V, Schoots IG, Smelov V, Travado L, Valdagni R, Wesselmann S, Wiegel T, van Poppel H.
The European Prostate Cancer Centres of Excellence: A Novel Proposal from the European Association of Urology Prostate Cancer Centre Consensus Meeting.
Eur Urol. 2019 Aug;76(2):179-186.
doi: 10.1016/j.eururo.2019.01.033. Epub 2019 Feb 22. PubMed PMID: 30799188.

Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Der Heijden AGV, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A.
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort(†): Under the Auspices of the EAU-ESMO Guidelines Committees.
Eur Urol. 2019 Nov 16. pii: S0302-2838(19)30763-8.
doi: 10.1016/j.eururo.2019.09.035. [Epub ahead of print] PubMed PMID: 31753752.